NRC
AH

North Run Capital’s Accretive Health AH Stock Holding History

North Run Capital’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,098,700
Closed -$19.1M – 29
2013
Q3 		$19.1M Sell
2,098,700
-811,300
-28% -$8.07M 2.49% 15
2013
Q2 		$31.5M Buy
+2,910,000
New +$30.6M 3.65% 12

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CII
CR Intrinsic Investors Stamford, Connecticut $2.67B AUM 28.43% 1-Year Est. Return

North Run Capital's AH Position: Q4 2013 in Review

North Run Capital sold out of Accretive Health (AH) in Q4 2013, closing a stake of 2,098,700 shares — an estimated $19.1M sold.

North Run Capital first reported a position in AH in Q2 2013 and held it in 2 quarters. The position peaked at $31.5M in Q2 2013. 85 funds tracked by Wall St. Rank hold AH as of Q4 2013.

  • North Run Capital reported no remaining Accretive Health position as of Q4 2013 after selling out during the quarter.
  • North Run Capital sold 2,098,700 Accretive Health shares in Q4 2013, an estimated $19.1M.
  • North Run Capital first reported a position in Accretive Health in Q2 2013 and held it in 2 quarters.
  • North Run Capital's Accretive Health position peaked at $31.5M in Q2 2013.
  • 85 funds tracked by Wall St. Rank held Accretive Health as of Q4 2013.

Based on North Run Capital's 13F filing for Q4 2013, filed 14 Feb 2014.